House Commerce Health Subcommittee Generics Hearing Planned For June
This article was originally published in The Tan Sheet
The House Energy & Commerce Committee/Health Subcommittee intends to hold a hearing on generic drug issues in June.
You may also be interested in...
The revised McCain/Schumer generic drug bill eliminates the automatic stay of approval under current patent challenge procedures.
Tax credits or reimbursements may be alternative incentives to encourage manufacturers to conduct pediatric studies, Rep. Frank Pallone (D-N.J.) suggested during a House Energy & Commerce/Health Subcommittee hearing May 3.
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC